Cooter Rodney Dean, Rudkin G E, Gardiner S E
Waverley House Plastic Surgery Centre, Level 1, Waverley House, 360 South Terrace, Adelaide, SA 5000, Australia.
Aesthetic Plast Surg. 2007 Nov-Dec;31(6):666-73. doi: 10.1007/s00266-006-0230-5.
An increasing trend toward day surgery management requires plastic surgeons not only to be cognizant of block techniques, but also to assess their safety and efficacy objectively. Paravertebral block offers benefits by enhancing surgical anesthesia and postoperative analgesia. This study aimed to assess the safety and efficacy of paravertebral block for day patients undergoing submuscular breast augmentation. The primary outcome measure was the rate of block failure. The secondary outcome measures included recovery room stay, pain management, and block complications. On the basis of a literature review and audit results, the study objective also aimed to propose safe guidelines for ambulatory paravertebral block patients undergoing breast surgery.
A total of 100 patients undergoing 172 single-level paravertebral blocks (72 bilateral blocks) and sedation for submuscular breast augmentation were studied prospectively. A single-injection paravertebral block was performed at the T4 level using a loss of resistance technique. Surgical, anesthetic, and recovery room details were recorded. Analyses were performed to determine the association between recovery room times, body mass index, pain scores, and requirements for opioids, antiemetics, and vasopressors.
The findings showed that 87% of the blocks were successful for surgical anesthesia and 94% of the blocks were successful for postoperative analgesia. The pain score for 74% of the subjects was 3 or less. Antiemetics were given for 10% of the patients with significantly longer recovery room times. Vasopressors were required for 6% of the patients. A surgically caused pneumothorax resulted in the only unplanned admission.
The study findings suggest that paravertebral block is a safe and effective technique for day case submuscular breast augmentation.
日间手术管理的趋势日益增加,这要求整形外科医生不仅要了解阻滞技术,还要客观评估其安全性和有效性。椎旁阻滞通过增强手术麻醉和术后镇痛带来益处。本研究旨在评估椎旁阻滞用于接受肌下隆乳术的日间手术患者的安全性和有效性。主要结局指标是阻滞失败率。次要结局指标包括恢复室停留时间、疼痛管理和阻滞并发症。基于文献综述和审计结果,研究目标还旨在为接受乳房手术的门诊椎旁阻滞患者提出安全指南。
前瞻性研究了总共100例接受172次单节段椎旁阻滞(7次双侧阻滞)并接受镇静以进行肌下隆乳术的患者。使用阻力消失技术在T4水平进行单次注射椎旁阻滞。记录手术、麻醉和恢复室的详细情况。进行分析以确定恢复室时间、体重指数、疼痛评分以及阿片类药物、止吐药和血管升压药需求之间的关联。
研究结果显示,87%的阻滞用于手术麻醉成功,94%的阻滞用于术后镇痛成功。74%的受试者疼痛评分为3分或更低。10%恢复室时间明显更长的患者使用了止吐药。6%的患者需要使用血管升压药。手术引起的气胸导致了唯一一次非计划入院。
研究结果表明,椎旁阻滞是日间肌下隆乳术的一种安全有效的技术。